chr3-41224069-A-T
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PVS1_SupportingPM2
The NM_001904.4(CTNNB1):c.1A>T(p.Met1?) variant causes a initiator codon change. The variant allele was found at a frequency of 0.000000684 in 1,461,532 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
CTNNB1
NM_001904.4 initiator_codon
NM_001904.4 initiator_codon
Scores
5
3
8
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 5.46
Publications
0 publications found
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
- exudative vitreoretinopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- severe intellectual disability-progressive spastic diplegia syndromeInheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics
- exudative vitreoretinopathy 7Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
PVS1
Start lost variant, no pathogenic variants between lost start and next in-frame start position. Next in-frame start position is after 8 codons. Genomic position: 41224534. Lost 0.009 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTNNB1 | NM_001904.4 | c.1A>T | p.Met1? | initiator_codon_variant | Exon 2 of 15 | ENST00000349496.11 | NP_001895.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTNNB1 | ENST00000349496.11 | c.1A>T | p.Met1? | initiator_codon_variant | Exon 2 of 15 | 1 | NM_001904.4 | ENSP00000344456.5 | ||
CTNNB1 | ENST00000645982.1 | c.1A>T | p.Met1? | initiator_codon_variant | Exon 2 of 16 | ENSP00000494845.1 | ||||
CTNNB1 | ENST00000715152.1 | n.1A>T | non_coding_transcript_exon_variant | Exon 2 of 16 | ENSP00000520353.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251376 AF XY: 0.00000736 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
251376
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461532Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727090 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1461532
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
727090
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33456
American (AMR)
AF:
AC:
0
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26110
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
0
AN:
86248
European-Finnish (FIN)
AF:
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1111750
Other (OTH)
AF:
AC:
0
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
DANN
Benign
DEOGEN2
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;.;.;.;T;.;T;T;T;.;T;T;T;T;T;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;D;D;.;D;.;.;.;D;.;.;.;.;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
PhyloP100
PROVEAN
Benign
.;.;N;.;D;.;N;N;N;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;N;.;.;N
REVEL
Benign
Sift
Pathogenic
.;.;D;.;.;.;D;D;D;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.;D
Sift4G
Benign
.;.;T;.;.;.;T;T;T;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;D
Polyphen
B;B;B;B;B;B;B;B;B;B;B;B;B;B;.;.;.;B;.;B;B;B;.;B;B;B;B;B;B
Vest4
0.88, 0.88, 0.88, 0.87
MutPred
Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);Gain of stability (P = 0.0553);
MVP
0.92
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.